Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Nathan Weisz, University of Konstanz
ClinicalTrials.gov Identifier:
NCT00748475
First received: September 5, 2008
Last updated: February 19, 2013
Last verified: February 2013
  Purpose

The purpose of the study is to examine the effect of alpha-neurofeedback while subjects listen to a noise on tinnitus.


Condition Intervention
Tinnitus
Behavioral: Neurofeedback

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus

Resource links provided by NLM:


Further study details as provided by University of Konstanz:

Primary Outcome Measures:
  • Reduction of tinnitus distress using the Tinnitus Questionaire [ Time Frame: Before the first and after the last session. ] [ Designated as safety issue: No ]
  • Cortical Alpha Power [ Time Frame: Before the first and after the last session ] [ Designated as safety issue: No ]

Enrollment: 12
Study Start Date: September 2008
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Neurofeedback Behavioral: Neurofeedback

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Duration of Tinnitus >= 6 months and <= 20 years
  • Subjective Tinnitus

Exclusion Criteria:

  • History of neurological or more than mild psychiatric diseases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00748475

Sponsors and Collaborators
University of Konstanz
Investigators
Principal Investigator: Nathan Weisz, PhD University Konstanz
Study Chair: Thomas Hartmann, Dipl.-Psych. University Konstanz
  More Information

No publications provided

Responsible Party: Nathan Weisz, Dr. Nathan Weisz, University of Konstanz
ClinicalTrials.gov Identifier: NCT00748475     History of Changes
Other Study ID Numbers: TE0602-1
Study First Received: September 5, 2008
Last Updated: February 19, 2013
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Tinnitus
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on September 18, 2014